91 related articles for article (PubMed ID: 16158939)
1. Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability.
Huang YT; Lee LT; Lee PP; Lin YS; Lee MT
Anticancer Res; 2005; 25(3B):2017-25. PubMed ID: 16158939
[TBL] [Abstract][Full Text] [Related]
2. Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells.
Lee LT; Huang YT; Hwang JJ; Lee AY; Ke FC; Huang CJ; Kandaswami C; Lee PP; Lee MT
Biochem Pharmacol; 2004 Jun; 67(11):2103-14. PubMed ID: 15135307
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs.
Han EK; Mcgonigal T; Wang J; Giranda VL; Luo Y
Anticancer Res; 2004; 24(6):3899-905. PubMed ID: 15736429
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
[TBL] [Abstract][Full Text] [Related]
6. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
[TBL] [Abstract][Full Text] [Related]
7. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.
van Nimwegen MJ; Verkoeijen S; van Buren L; Burg D; van de Water B
Cancer Res; 2005 Jun; 65(11):4698-706. PubMed ID: 15930288
[TBL] [Abstract][Full Text] [Related]
8. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.
Huang YT; Hwang JJ; Lee PP; Ke FC; Huang JH; Huang CJ; Kandaswami C; Middleton E; Lee MT
Br J Pharmacol; 1999 Nov; 128(5):999-1010. PubMed ID: 10556937
[TBL] [Abstract][Full Text] [Related]
9. [Focal adhesion kinase and mitogen activated protein kinase are involved in vascular smooth muscle cells migration and proliferation stimulated by fibronectin].
Yin H; Wang L; Huo Y; Peng X; Xia C; Tang C
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):622-5. PubMed ID: 12133485
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species increased focal adhesion kinase production in pulmonary microvascular endothelial cells.
Yang S; Yip R; Polena S; Sharma M; Rao S; Griciene P; Gintautas J; Jerome H
Proc West Pharmacol Soc; 2004; 47():54-6. PubMed ID: 15633612
[TBL] [Abstract][Full Text] [Related]
11. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.
Natarajan M; Stewart JE; Golemis EA; Pugacheva EN; Alexandropoulos K; Cox BD; Wang W; Grammer JR; Gladson CL
Oncogene; 2006 Mar; 25(12):1721-32. PubMed ID: 16288224
[TBL] [Abstract][Full Text] [Related]
12. Growth factors stimulate kidney proximal tubule cell migration independent of augmented tyrosine phosphorylation of focal adhesion kinase.
Cao Y; Baig MR; Hamm LL; Wu K; Simon EE
Biochem Biophys Res Commun; 2005 Mar; 328(2):560-6. PubMed ID: 15694384
[TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase signaling pathway participates in the formation of choroidal neovascularization and regulates the proliferation and migration of choroidal microvascular endothelial cells by acting through HIF-1 and VEGF expression in RPE cells.
Zhu J; Wang YS; Zhang J; Zhao W; Yang XM; Li X; Jiang TS; Yao LB
Exp Eye Res; 2009 May; 88(5):910-8. PubMed ID: 19111720
[TBL] [Abstract][Full Text] [Related]
14. The C-terminal domain of focal adhesion kinase reduces the tumor cell invasiveness in chondrosarcoma cell lines.
Lee JW; Hee Kim Y; Boong Park H; Xu LH; Cance WG; Block JA; Scully SP
J Orthop Res; 2003 Nov; 21(6):1071-80. PubMed ID: 14554221
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway.
van Seventer GA; Salmen HJ; Law SF; O'Neill GM; Mullen MM; Franz AM; Kanner SB; Golemis EA; van Seventer JM
Eur J Immunol; 2001 May; 31(5):1417-27. PubMed ID: 11465098
[TBL] [Abstract][Full Text] [Related]
16. The focal adhesion kinase--a regulator of cell migration and invasion.
Hauck CR; Hsia DA; Schlaepfer DD
IUBMB Life; 2002 Feb; 53(2):115-9. PubMed ID: 12049193
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
18. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells.
Slack JK; Adams RB; Rovin JD; Bissonette EA; Stoker CE; Parsons JT
Oncogene; 2001 Mar; 20(10):1152-63. PubMed ID: 11313859
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase promotes the aggressive melanoma phenotype.
Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
